Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DICARE
- Development stage
- Unknown
- Lead developer
- Ergon Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
DICARE is an Ayurvedic herbal medicine developed by Ergon Pharmaceuticals and included in the Bangladesh National Ayurvedic Formulary (BNAF). It is formulated as a 300 mg capsule, with its primary active ingredient being *Rehmannia glutinosa* (also known as Di-huang or Yellow Earth). The product is indicated for the treatment of all types of diabetes, as well as hepatitis, viral hepatitis, and internal hemorrhage. Its mechanism of action involves regulating pancreatic function to stimulate insulin secretion and blocking the absorption of sugar from the gastrointestinal tract to maintain healthy blood glucose levels.
- Brand names
- DICARE
- Other names
- Capsule DICARE
Beyond the preview
Go deeper on DICARE.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DICARE.